Basic Information
| LncRNA/CircRNA Name | DLX6-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:96955141-97014065 |
| Ensemble | ENSG00000231764 |
| Refseq | NR_015448 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay |
| Sample | OS tissues, OS cell lines |
| Expression Pattern | up-regulated |
| Function Description | DLX6-AS1 was found to be significantly upregulated in OS tissues and OS cell lines. |
| Pubmed ID | 30838699 |
| Year | 2019 |
| Title | LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway. |
External Links
| Links for DLX6-AS1 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |